Moreover, IGFL2-AS1 binds to HNRNPC via m6A modification to regulate TP53INP2 expression in RCC cells, which enhances the sunitinib resistance of RCC cells [39]. This evidence concerns the gene IGFL2 and renal cell carcinoma.